DrugDashboards

Norepinephrine Bitartrate

Norepinephrine Bitartrate · NOREPINEPHRINE BITARTRATE 1 mg/mL · Injection, Solution · Intravenous · Sagent Pharmaceuticals

NDC 25021-0316-04 · 10 VIAL in 1 CARTON / 4 mL in 1 VIAL · ANDA · View full market →

The short version

4 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$80.00
Reported to Texas DSHS · 2026 annual filing · Sagent Pharmaceuticals

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA214323
TE code
AP
Approval date
May 6, 2021
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Norepinephrine Bitartrate (Injection, Solution)

LabelerStrengthFirst seenLast seen
Baxter Healthcare CorporationNOREPINEPHRINE BITARTRATE 4 mg/250mLJul 15, 2026Sep 3, 2026
Baxter Healthcare CorporationNOREPINEPHRINE BITARTRATE 8 mg/250mLJul 15, 2026Sep 3, 2026
Avenacy, LLCNOREPINEPHRINE BITARTRATE 1 mg/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsNOREPINEPHRINE BITARTRATE 1 mg/mLJul 15, 2026Sep 2, 2026
WG Critical Care, LLCNOREPINEPHRINE BITARTRATE .128 mg/mLJul 15, 2026Sep 2, 2026
WG Critical Care, LLCNOREPINEPHRINE BITARTRATE .016 mg/mLJul 15, 2026Sep 2, 2026
WG Critical Care, LLCNOREPINEPHRINE BITARTRATE .064 mg/mLJul 15, 2026Sep 2, 2026
WG Critical Care, LLCNOREPINEPHRINE BITARTRATE .032 mg/mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationNOREPINEPHRINE BITARTRATE 16 mg/250mLJul 15, 2026Aug 31, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Norepinephrine Bitartrate — NDC 25021-0316-04," retrieved September 3, 2026, https://drugdashboards.com/drug/25021031604.

Free to cite with attribution — see how the data is put together.